We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Doctors Angela Vidal and Xavier Montalban
The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.
The multicenter study, coordinated by Dr. Xavier Montalban, director of the Multiple Sclerosis Center of Catalonia (Cemcat), the Neurology Service of the Vall d'Hebron University Hospital and the Clinical Neuroimmunology research group of the Vall d'Hebron Research Institute (VHIR), shows that the incorporation of the optic nerve into the diagnostic criteria would improve the ability to detect cases of multiple sclerosis.
"Inflammation of the optic nerve, or optic neuritis, is one of the most common manifestations of multiple sclerosis. In fact, one third of patients present it as the first symptom and seven out of ten develop it during the course of the disease," explains Dr. Angela Vidal Jordana, research neurologist at Cemcat, principal investigator of the Clinical Neuroimmunology group at VHIR and first author of the paper published in the journal Neurology. "However, nowadays, lesions in the optic nerve are not considered within the diagnostic criteria."
To diagnose multiple sclerosis, the McDonald criteria state that it is necessary to demonstrate spatial dissemination of demyelinating lesions. That is, involvement of at least two of four certain regions of the brain and spinal cord at different times. "The last revision of the McDonald criteria took place in 2017. Then, the optic nerve was not included as one of the regions of the central nervous system to be considered to confirm dissemination in space, due to a lack of data on its diagnostic utility. Consequently, when a patient arrives at the clinic with optic neuritis, but only one of the areas included in the criteria is affected, diagnosis and treatment are delayed until the appearance of a lesion in a second region," says Vidal Jordana.
The study involved 157 patients from 5 centers in the European Magnetic Resonance Imaging for Multiple Sclerosis (MAGNIMS) network. "The aim of our work was, on the one hand, to determine the impact of including optic nerve lesions in the diagnostic criteria. On the other, we sought to evaluate the ability of three tests, optic nerve MRI, optical coherence tomography and visual evoked potentials, to detect these damages," states Vidal Jordana. Data on optic nerve function were collected within six months of disease onset, using at least two of the three techniques.
According to the results, the inclusion of the optic nerve as a fifth study area improves sensitivity and diagnostic performance compared to the McDonald 2017 criteria. "We are talking about 92.5% sensitivity of the modified criteria versus 88.2% of the current criteria", specifies Montalban. "The strength of our proposal is that it does not change the minimum number of regions affected by concluding the diagnosis of multiple sclerosis. The McDonald criteria require lesions in two out of four regions. We maintain this two-region condition, but add a fifth area, the optic nerve, for those cases that do not quite meet the classic criteria. In other words, if magnetic resonance imaging already allows us to establish a clear diagnosis, it is not necessary to assess the function of the optic nerve".
Finally, the researchers emphasize that the modified criteria are applicable to any center that has one of the three techniques used in the study to evaluate the optic nerve, as they have similar performance.
Inflammation of the optic nerve, or optic neuritis, is one of the most common manifestations of multiple sclerosis. In fact, one third of patients present it as the first symptom.
Neurology, General Hospital
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.